BEGIN:VCALENDAR
PRODID:-//Session events Calendar//IBA//EN
CALSCALE:GREGORIAN
VERSION:2.0
BEGIN:VEVENT
DTSTAMP:20260404T164438Z
DTSTART:20260604T155000Z
DTEND:20260604T165000Z
SUMMARY:PANEL FOUR - Life sciences M&A in uncertain markets – earnouts\, 
 CVRs\, contingent milestones\, and IP-driven valuation mechanics/late-st
 age private financings and IPO alternatives (crossovers\, structured pre
 ferred\, PIPEs\, ATMs and registered directs)[
DESCRIPTION:This panel will examine how volatility\, regulatory complexit
 y and shifting capital markets are reshaping transactional structures an
 d financing strategies in the life sciences sector. Speakers will discus
 s the growing use of earnouts\, contingent value rights\, milestone base
 d payments and IP driven valuation mechanisms as tools to bridge valuati
 on gaps and allocate risk in M&amp\;A transactions involving biotech\, p
 harma and healthtech companies. The discussion will also address late st
 age private financing alternatives to traditional IPOs\, including cross
 overs\, structured preferred equity\, PIPEs\, at the market offerings an
 d registered directs\, analysing their legal\, governance and disclosure
  implications. Drawing on cross border experience\, the panel will offer
  practical insights into structuring deals that balance investor protect
 ion\, innovation incentives and long term value creation in an increasin
 gly uncertain global market.
LOCATION:
UID:fa3a77e6-12fb-4e16-8747-3e7e26d9cfa7
END:VEVENT
END:VCALENDAR